Back
Ascendis Pharma A/S Stock Price Chart
DeFi Coin Triggers All "Buy" Signals And Could Break Out Soon
Discover our top DeFi pick for potentially massive gains now (before it's too late).
Sell
33
ASND
Ascendis Pharma A/S
Last Price:
137.07
Seasonality Move:
2.6%
7 Day Trial
ALL ACCESS PASS
$
7
20 Most Hated Stocks on Wall Street
Click here to see the full list and protect yourself before it's too late.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ASND is experiencing slight selling pressure.
Ascendis Pharma A/S Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 140.18 | Buy |
| 20-day SMA: | 143.81 | Sell |
| 50-day SMA: | 147.28 | Sell |
| 200-day SMA: | 116.95 | Buy |
| 8-day EMA: | 140.49 | Buy |
| 20-day EMA: | 142.67 | Sell |
| 50-day EMA: | 143.37 | Sell |
| 200-day EMA: | 125.06 | Buy |
Ascendis Pharma A/S Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.18 | Sell |
| Relative Strength Index (14 RSI): | 45.98 | Sell |
| Chaikin Money Flow: | -67743 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (139.82 - 150) | Sell |
| Bollinger Bands (100): | (128.4 - 151.26) | Buy |
Ascendis Pharma A/S Technical Analysis
| Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Ascendis Pharma A/S Stock
Is Ascendis Pharma A/S Stock a Buy?
- Ascendis Pharma A/S share price is 141.10 while ASND 8-day simple moving average is 140.18, which is a Buy signal.
- The stock price of ASND is 141.10 while Ascendis Pharma A/S 20-day SMA is 143.81, which makes it a Sell.
- Ascendis Pharma A/S 50-day simple moving average is 147.28 while ASND share price is 141.10, making it a Sell technically.
- ASND stock price is 141.10 and Ascendis Pharma A/S 200-day simple moving average is 116.95, creating a Buy signal.
ASND Technical Analysis vs Fundamental Analysis
Sell
33
Ascendis Pharma A/S (ASND)
is a Sell
Is Ascendis Pharma A/S a Buy or a Sell?
-
Ascendis Pharma A/S stock is rated a Sell
The current Ascendis Pharma A/S [ASND] share price is $141.10. The Score for ASND is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
Ascendis Pharma A/S Stock Info
Market Cap:
7.99B
Price in USD:
141.10
Share Volume:
305.17K
Ascendis Pharma A/S 52-Week Range
52-Week High:
161.00
52-Week Low:
83.75
Sell
33
Ascendis Pharma A/S (ASND)
is a Sell
Ascendis Pharma A/S Share Price Forecast
-
What is the Ascendis Pharma A/S stock price today?
The Ascendis Pharma A/S stock price is 141.10 USD today. -
Will ASND stock go up or go down?
Ascendis Pharma A/S> share price is forecast to RISE/FALL based on technical indicators -
Is Ascendis Pharma A/S overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Ascendis Pharma A/S is overvalued.
Is Ascendis Pharma A/S Stock a Buy?
- Ascendis Pharma A/S share price is 141.10 while ASND 8-day exponential moving average is 140.49, which is a Buy signal.
- The stock price of ASND is 141.10 while Ascendis Pharma A/S 20-day EMA is 142.67, which makes it a Sell.
- Ascendis Pharma A/S 50-day exponential moving average is 143.37 while ASND share price is 141.10, making it a Sell technically.
- ASND stock price is 141.10 and Ascendis Pharma A/S 200-day simple moving average is 125.06, creating a Buy signal.
Fundamental Analysis of Ascendis Pharma A/S
Is Ascendis Pharma A/S a good investment?
- Analysts estimate an earnings increase this quarter of $1.52 per share, an increase next quarter of $1.19 per share, an increase this year of $4.56 per share, and an increase next year of $4.16 per share.
Technical Analysis of Ascendis Pharma A/S
Should I short Ascendis Pharma A/S stock?
- ASND Moving Average Covergence Divergence (MACD) indicator is -2.18, suggesting Ascendis Pharma A/S is a Sell
- Ascendis Pharma A/S Relative Strength Index (RSI) is 45.98, which suggest Ascendis Pharma A/S is oversold
- The Bollinger Bands (25) for Ascendis Pharma A/S is (139.82 - 150), which suggest Ascendis Pharma A/S is a Buy
- The Bollinger Bands (100) for Ascendis Pharma A/S is (128.4 - 151.26), which suggest Ascendis Pharma A/S is a Buy
* Ascendis Pharma A/S stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.